More sensitive cytokine-specific ELISA assays were performed to assess whether plasma concentrations of GM-CSF, IL-2 and/or VEGF could be considered as potential candidate biomarkers of schistosomiasis infection and/or liver fibrosis (Figures 3A, E, I). This evidence concerns the gene IL2 and Hepatic fibrosis.